53 related articles for article (PubMed ID: 8593818)
21. The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment.
Fissore F; Fortunati N; Comba A; Fazzari A; Gaidano G; Berta L; Frairia R
Steroids; 1994 Nov; 59(11):661-7. PubMed ID: 7701543
[TBL] [Abstract][Full Text] [Related]
22. MCF-7 cell progesterone receptor (PGR) is additionally modulated by sex steroid binding protein (SBP) and its membrane receptor (SBP-R) through cAMP and PKA.
Fortunati N; Comba A; Becchis M; Catalano MG; Fazzari A; Fissore F; Frairia R
Ann N Y Acad Sci; 1996 Apr; 784():453-7. PubMed ID: 8651597
[No Abstract] [Full Text] [Related]
23. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).
Fortunati N; Fissore F; Fazzari A; Piovano F; Catalano MG; Becchis M; Berta L; Frairia R
J Steroid Biochem Mol Biol; 1999; 70(1-3):73-80. PubMed ID: 10529004
[TBL] [Abstract][Full Text] [Related]
24. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
Cho H; Aronica SM; Katzenellenbogen BS
Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
[TBL] [Abstract][Full Text] [Related]
25. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase A.
Fortunati N; Fissore F; Fazzari A; Becchis M; Comba A; Catalano MG; Berta L; Frairia R
Endocrinology; 1996 Feb; 137(2):686-92. PubMed ID: 8593818
[TBL] [Abstract][Full Text] [Related]
26. Sex steroid-binding protein and its membrane receptor in estrogen-dependent breast cancer: biological and pathophysiological impact.
Fortunati N; Fissore F; Comba A; Becchis M; Catalano MG; Fazzari A; Berta L; Frairia R
Horm Res; 1996; 45(3-5):202-6. PubMed ID: 8964584
[TBL] [Abstract][Full Text] [Related]
27. Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells.
Fortunati N; Becchis M; Catalano MG; Comba A; Ferrera P; Raineri M; Berta L; Frairia R
J Steroid Biochem Mol Biol; 1999; 69(1-6):473-9. PubMed ID: 10419027
[TBL] [Abstract][Full Text] [Related]
28. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.
Fortunati N; Catalano MG
Horm Metab Res; 2006 Apr; 38(4):236-40. PubMed ID: 16700004
[TBL] [Abstract][Full Text] [Related]
29. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
Ciardiello F; Tortora G
Clin Cancer Res; 1998 Apr; 4(4):821-8. PubMed ID: 9563874
[TBL] [Abstract][Full Text] [Related]
30. Sex hormone-binding globulin: not only a transport protein. What news is around the corner?
Fortunati N
J Endocrinol Invest; 1999 Mar; 22(3):223-34. PubMed ID: 10219893
[TBL] [Abstract][Full Text] [Related]
31. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate.
Rosner W; Hryb DJ; Khan MS; Nakhla AM; Romas NA
Steroids; 1999; 64(1-2):100-6. PubMed ID: 10323678
[TBL] [Abstract][Full Text] [Related]
32. cAMP-dependent protein kinase: role in normal and malignant growth.
Cho-Chung YS; Pepe S; Clair T; Budillon A; Nesterova M
Crit Rev Oncol Hematol; 1995 Nov; 21(1-3):33-61. PubMed ID: 8822496
[No Abstract] [Full Text] [Related]
33. Alternative mechanisms of action of anti-oestrogens.
Colletta AA; Benson JR; Baum M
Breast Cancer Res Treat; 1994; 31(1):5-9. PubMed ID: 7981456
[TBL] [Abstract][Full Text] [Related]
34. Sex hormone-binding globulin: anatomy and physiology of a new regulatory system.
Rosner W; Hryb DJ; Khan MS; Nakhla AM; Romas NA
J Steroid Biochem Mol Biol; 1991; 40(4-6):813-20. PubMed ID: 1659894
[TBL] [Abstract][Full Text] [Related]
35. Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
Cho-Chung YS
Proc Assoc Am Physicians; 1997 Jan; 109(1):23-32. PubMed ID: 9010913
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expression.
Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 1996; 6(3):237-44. PubMed ID: 8915509
[TBL] [Abstract][Full Text] [Related]
37. Suppression of malignancy targeting cyclic AMP signal transducing proteins.
Cho-Chung YS
Biochem Soc Trans; 1992 May; 20(2):425-30. PubMed ID: 1327918
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
